Subscribe for the newsletter
Mobile Navigation
Subscribe for the Newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Cipher Pharmaceuticals Inc
Sort By
Newest First
Sign in
1 / 1
1 / 1
Acquistion
Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE® from Synergy Pharmaceuticals
Cipher Pharmaceuticals Inc.
PR-M03-18-NI-012
Mar 02, 2018
